Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. CCH:LN
5. META
6. CCHGY
7. PRY:IM
8. PRYMY
9. SKA-B
10. PBA

Go back to Relmada Therapeutics Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
(NASDAQ: RLMD) Delayed: 6.28 -0.11 (1.72%)
Previous Close $6.39    52 Week High $4.10 
Open $6.44    52 Week Low $0.87 
Day High $6.61    P/E N/A 
Day Low $6.27    EPS $0.00 
Volume 1,449,051